๐ฐ Access Program News
Page 121 - Access Program News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Access Program. Real-time updates on events, politics, business and more.
October 18, 2023
/PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today issues its Appendix 4C quarterly cash flow report and accompanying...
October 18, 2023
(BPT) - COVID-19 is still here, and sadly, we still see deaths due to the virus. CDC recommends everyone 6 months and older get an updated COVID-19 vaccine to protect against getting seriously sick โฆ
October 17, 2023
The University of Alabama announced last week that a member of its Alabama Small Business Development Center (SBDC) has been recognized as the winner of the SBDC's national branch's Top 40 Under 40 category which recognizes 40 leaders under the age of 40 who have displayed exceptional business acumen and innovative thinking.
October 17, 2023
Including why you're seeing those commercials, and how it differs from mRNA vaccines.
October 17, 2023
The newly formulated COVID-19 vaccine is now available in the Kansas City area. Here’s what we know about it and where to get one.
October 16, 2023
Tiziana Life Sciences Ltd (NASDAQ:TLSA)ย announcedย that a reduction in activated microglia, as seen in six-month Positron Emission Tomography (PET) scans,...
October 16, 2023
The Michigan Department of Health and Human Services (MDHHS) is recommending residents get the flu, COVID-19 and RSV vaccines to protect themselves and their co
October 16, 2023
Radio Station WHMI 93.5 FM โ Livingston County Michigan News, Weather, Traffic, Sports, School Updates, and the Best Classic Hits for Howell, Brighton, Fenton
October 16, 2023
CHICAGO The Illinois Department of Public Health (IDPH) said today that although data indicates COVID-19 hospitalizations are at a low level across the
October 16, 2023
Tiziana Life Sciences Ltd. (TLSA), a clinical-stage biopharmaceutical company, announced Monday positive six-month clinical results in multiple sclerosis patients treated with intranasal Foralumab.